| Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis (NCT03847389) | Hill Dermaceuticals, Inc. | 2019-09-09 |
| PLX51107 and Azacitidine in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT04022785) | M.D. Anderson Cancer Center | 2019-09-09 |
| A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 (NCT04065295) | Boehringer Ingelheim | 2019-09-09 |
| A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis (NCT04090229) | ASLAN Pharmaceuticals | 2019-09-09 |
| AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects (NCT04107441) | Axalbion SA | 2019-09-09 |
| Clinical Trial to Evaluate the Safety and Tolerability of Lagricel® Ofteno Multi-dose Ophthalmic Solution (NCT04081610) | Laboratorios Sophia S.A de C.V. | 2019-09-09 |
| Effect of Vitamin D Supplementation on Improvement of Pneumonic Children (NCT04244474) | Cairo University | 2019-09-09 |
| Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris (NCT04321070) | Sun Pharmaceutical Industries, Inc. | 2019-09-09 |
| Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects (NCT04152759) | Bio-Thera Solutions | 2019-09-09 |
| Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis (NCT04043819) | Personalized Stem Cells, Inc. | 2019-09-07 |
| Safety of Bosentan in Type II Diabetic Patients (NCT04068272) | Retinset SL | 2019-09-07 |
| Effect of Omeprazole on PK of Fluzoparib in Healthy Male Subjects (NCT04108676) | Jiangsu HengRui Medicine Co., Ltd. | 2019-09-07 |
| A Randomized, Blinded, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Preliminary Immunogenicity of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years (NCT04083196) | National Vaccine and Serum Institute, China | 2019-09-07 |
| Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting) (NCT04083872) | Chong Kun Dang Pharmaceutical | 2019-09-06 |
| Niraparib in Combination With Trastuzumab in Metastatic HER2+ Breast Cancer (NCT03368729) | University of Alabama at Birmingham | 2019-09-06 |
| Safety and Proof-of-Concept (POC) Study With AMT-130 in Adults With Early Manifest Huntington's Disease (NCT04120493) | UniQure Biopharma B.V. | 2019-09-06 |
| An Investigational Immunotherapy Study of BMS-986288 Alone and in Combination With Nivolumab in Advanced Solid Cancers (NCT03994601) | Bristol-Myers Squibb | 2019-09-06 |
| Study of the Safety and Efficacy of Gemtuzumab Ozogamicin (GO) and Venetoclax in Patients With Relapsed or Refractory CD33+ Acute Myeloid Leukemia:Big Ten Cancer Research Consortium BTCRC-AML17-113 (NCT04070768) | John Quigley | 2019-09-06 |
| A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults (NCT04083716) | Assembly Biosciences | 2019-09-06 |
| Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed) (NCT04083846) | Chong Kun Dang Pharmaceutical | 2019-09-06 |
| Pemetrexed for the Treatment of Chordoma (NCT03955042) | Saint John's Cancer Institute | 2019-09-06 |
| Single Ascending Dose Study of PBI-4547 in Healthy Subjects (NCT04068259) | Liminal BioSciences Ltd. | 2019-09-05 |
| A Phase Ib Study of HX008 in Patients With Advanced Solid Tumors (NCT04825392) | Taizhou Hanzhong biomedical co. LTD | 2019-09-05 |
| A Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor (NCT04078295) | Eisai Co., Ltd. | 2019-09-05 |
| Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers (NCT04092712) | Concert Pharmaceuticals | 2019-09-05 |
| Dose Finding Study of L19TNF and Doxorubicin in Patients With STS (NCT04032964) | Philogen S.p.A. | 2019-09-05 |
| Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET (NCT03993873) | Turning Point Therapeutics, Inc. | 2019-09-05 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ABP-671 (NCT04060173) | Atom Therapeutics Co., Ltd | 2019-09-05 |
| Investigation of Mechanisms of Action in Superpower Glass (NCT04049981) | Stanford University | 2019-09-04 |
| A Study in Healthy Men to Test Whether Rifampicin Influences the Amount of BI 894416 in the Blood (NCT04060719) | Boehringer Ingelheim | 2019-09-04 |
| A Study of Lazertinib as Monotherapy or in Combination With Amivantamab in Participants With Advanced Non-small Cell Lung Cancer (NCT04077463) | Janssen Research & Development, LLC | 2019-09-04 |
| A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairment (NCT03983161) | Celgene | 2019-09-04 |
| Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation (NCT03755414) | Washington University School of Medicine | 2019-09-04 |
| Study of Subcutaneous and Intravenous ALXN1720 With and Without rHuPH20 in Healthy Subjects (NCT04920370) | Alexion Pharmaceuticals, Inc. | 2019-09-04 |
| RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome (NCT04021368) | Ryvu Therapeutics SA | 2019-09-04 |
| An Immunogenic Personal Neoantigen Vaccine for Cancer Treatment (NCT04087252) | Henan Cancer Hospital | 2019-09-04 |
| Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects (NCT04079790) | GlaxoSmithKline | 2019-09-04 |
| Study of ImmunoPet Imaging of PD-L1 in Tumors Using 89Zr-DFO-REGN3504 in Adult Participants With Advanced PD-L1 Positive Malignancies (NCT03746704) | Regeneron Pharmaceuticals | 2019-09-04 |
| A Study of LY3475766 in Healthy Participants (NCT04052594) | Eli Lilly and Company | 2019-09-03 |
| A Study of ALRN-6924 for the Prevention of Chemotherapy-induced Side Effects (Chemoprotection) (NCT04022876) | Aileron Therapeutics, Inc. | 2019-09-03 |
| Safety and Immunogenicity of the Bris10 M2SR and Sing2016 M2SR H3N2 Monovalent Influenza Vaccines (NCT03999554) | FluGen Inc | 2019-09-03 |
| Study on PK of Hydronidone in Patients and Special Population (NCT04123769) | Beijing Continent Pharmaceutical Co, Ltd. | 2019-09-03 |
| Evaluation of Clinical Performance for Recent Non Coated Glass Ionomer in Posterior Teeth (NCT04463342) | Cairo University | 2019-09-03 |
| A Study of an Intratumoral Oncolytic Virus in Patients With Advanced Metastatic Solid Tumors (NCT03954067) | Astellas Pharma Global Development, Inc. | 2019-09-03 |
| A Study of SGN-CD228A in Advanced Solid Tumors (NCT04042480) | Seagen Inc. | 2019-09-03 |
| Study of CM310 in Healthy Subjects (NCT06161090) | Keymed Biosciences Co.Ltd | 2019-09-03 |
| Nozin in Preventing Respiratory Viral Infections in Patients Undergoing Stem Cell Transplant, PREV-NOSE STUDY (NCT04060849) | Fred Hutchinson Cancer Center | 2019-09-03 |
| A Phase I/II Study of AST-3424 in Subjects With Advanced Solid Tumors (NCT06239155) | Ascentawits Pharmaceuticals, Ltd | 2019-09-03 |
| A Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO7234292 (RG6042) in CSF and Plasma, and Safety and Tolerability Following Intrathecal Administration in Patients With Huntington's Disease (NCT04000594) | Hoffmann-La Roche | 2019-09-02 |
| Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients. (NCT03978494) | Sandoz | 2019-09-02 |
| A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants (NCT04056117) | LimmaTech Biologics AG | 2019-09-02 |
| Study to Investigate the Safety, Blood Levels and Activity of MP0310 in Patients With Advanced Solid Tumors (NCT04049903) | Molecular Partners AG | 2019-09-02 |
| Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors (NCT03992326) | Centre Hospitalier Universitaire Vaudois | 2019-09-01 |
| PDR001 + Panobinostat for Melanoma and NSCLC (NCT03982134) | Muhammad Furqan | 2019-09-01 |
| tDCS to Increase Aerobic Performance in Runners (NCT04005846) | University of Liege | 2019-09-01 |
| Behavioral Effects of Drugs (Inpatient): 40 [Methamphetamine, Methylphenidate, Duloxetine] (NCT04178993) | Craig Rush | 2019-09-01 |
| A Monotherapy in Subjects With Advanced Solid Tumors (NCT04221204) | 3D Medicines (Beijing) Co., Ltd. | 2019-09-01 |
| Sustained Acoustic Medicine (SAM) Combined With a Diclofenac Ultrasound Coupling Patch for Knee Osteoarthritis (NCT04391842) | ZetrOZ, Inc. | 2019-09-01 |
| Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole (NCT04120311) | Targeted Therapy Technologies, LLC | 2019-09-01 |
| Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy. (NCT04552600) | Natureceuticals Sdn Bhd | 2019-09-01 |
| Antisecretory Factor in Primary Glioblastoma 1 (NCT04116138) | Peter Siesjö | 2019-09-01 |
| Development of Pregnenolone as a Treatment for Depression (NCT03645096) | University of Texas Southwestern Medical Center | 2019-09-01 |
| Effects of Cannabidiol in Alcohol Use Disorder (NCT03252756) | NYU Langone Health | 2019-09-01 |
| Speech Recognition Training in Children With Hearing Loss (NCT04041440) | Washington University School of Medicine | 2019-09-01 |
| A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine (NCT05680454) | Beijing Health Guard Biotechnology, Inc | 2019-09-01 |
| CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia (NCT04265963) | Chongqing Precision Biotech Co., Ltd | 2019-09-01 |
| Autologous CAR-T/TCR-T Cell Immunotherapy for Solid Malignancies (NCT03941626) | Shenzhen BinDeBio Ltd. | 2019-09-01 |
| Decorin in Sub Scleral Trabeculectomy (NCT03924544) | Cairo University | 2019-09-01 |
| Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking (NCT03918408) | Pacific Clear Vision Institute | 2019-09-01 |
| CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma (NCT04649983) | Chongqing Precision Biotech Co., Ltd | 2019-09-01 |
| Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort (NCT03900442) | Prescient Therapeutics, Ltd. | 2019-09-01 |
| PentoxIfylline and Tocopherol for the Treatment of Post-radiotherapy Fibrosis in Head and Neck Cancer Patients (NCT03723291) | University College, London | 2019-09-01 |
| Evaluation of Marginal Integrity Using Bioactive Cement Incementation of Indirect Composite Blocks (NCT04557657) | Cairo University | 2019-09-01 |
| Ex-vivo Expanded γδ T Lymphocytes in Patients With Refractory/Relapsed Acute Myeloid Leukaemia (NCT04008381) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2019-09-01 |
| Treatment of Renal Stones With Frankincense (Luban) (NCT03924596) | Sultan Qaboos University | 2019-09-01 |
| Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD (NCT04269850) | St. Petersburg State Pavlov Medical University | 2019-09-01 |
| Health Service Intervention for the Improvement of Access and Adherence to Colorectal Cancer Screening (NCT04607291) | Roswell Park Cancer Institute | 2019-09-01 |
| Study to Assess Sarilumab in Halting Progression of Morphea (NCT03679845) | Massachusetts General Hospital | 2019-09-01 |
| Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions (NCT03899298) | R3 Stem Cell | 2019-09-01 |
| Evaluation of Kisspeptin Glucose-Stimulated Insulin Secretion With Physiologic Mixed Meal Tolerance (NCT04532801) | Stephanie B. Seminara, MD | 2019-09-01 |
| A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation (NCT04024761) | Dana-Farber Cancer Institute | 2019-08-31 |
| A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I (NCT03812263) | Rocket Pharmaceuticals Inc. | 2019-08-30 |
| ABX196 in Combination With Nivolumab in Patients With Hepatocellular Carcinoma (NCT03897543) | Abivax S.A. | 2019-08-30 |
| Study for Multiple Doses of HM15136(Efpegerglucagon) in Obese or Overweight Subjects With Comorbidities (NCT04167553) | Hanmi Pharmaceutical Company Limited | 2019-08-30 |
| Study to Compare the Pharmacokinetics of Tricaprilin Formulations and a Placebo on Ketone Body Production (NCT03971123) | Cerecin | 2019-08-30 |
| A Study of GFH018 in Patients With Advanced Solid Tumors (NCT05051241) | Zhejiang Genfleet Therapeutics Co., Ltd. | 2019-08-30 |
| Safety, Tolerability of OP-724 in Patients With Primary Biliary Cholangitis (Phase I) (NCT04047160) | Kiminori Kimura, MD | 2019-08-29 |
| Study to Assess Safety, Tolerability and Reactogenicity of Vaccine "UniFluVec" After Two Intranasal Administrations in Healthy Volunteers (NCT04650971) | Pharmenterprises Biotech LLC | 2019-08-29 |
| Study of UB-312 in Healthy Participants and Parkinson's Disease Patients (NCT04075318) | United Neuroscience Ltd. | 2019-08-29 |
| Study of ADG116 in Patients With Advanced/Metastatic Solid Tumors (NCT04111445) | Adagene Inc | 2019-08-29 |
| Study of Ibrutinib in Combination With Revlimid/Dexamethasone in Relapsed/Refractory Multiple Myeloma (NCT03702725) | Alliance Foundation Trials, LLC. | 2019-08-29 |
| Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors (NCT04034238) | National Cancer Institute (NCI) | 2019-08-29 |
| Study of Safety and Pharmacokinetics of Oral Doses of EPX-100 in Healthy Subjects. (NCT04069689) | Epygenix | 2019-08-29 |
| Fasting Bioequivalence Study of 2 Progesterone Soft Capsules 200 mg in 66 Healthy Female Subjects Under Vaginal Route (NCT05125627) | Joint Stock Company "Farmak" | 2019-08-28 |
| Drug-Drug Interaction Study Between Henagliflozin Proline and Hydrochlorothiazide (NCT06083116) | Jiangsu HengRui Medicine Co., Ltd. | 2019-08-28 |
| A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole (NCT04139226) | Amgen | 2019-08-28 |
| Clinical Trial for the Investigational Drug (PB-201) in Subjects With Type 2 Diabetes Mellitus (NCT03973515) | PegBio Co., Ltd. | 2019-08-27 |
| A Study of RBT-1 in Healthy Volunteers and Subjects With Stage 3/4 Chronic Kidney Disease (NCT03893799) | Renibus Therapeutics, Inc. | 2019-08-27 |
| Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy Subjects (NCT04053023) | GlaxoSmithKline | 2019-08-27 |
| Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma (NCT03957551) | John Rieth | 2019-08-27 |